Nutraceuticals in Nanomedicine Applications
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (1 September 2023) | Viewed by 20204
Special Issue Editors
2. Biomedical Sciences, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USA
Interests: nanomedicine; nutraceuticals; targeted delivery of therapeutics and contrasts; pharmaceutical formulations; cancer and cardiovascular pharmacotherapies
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; nanoparticle toxicology; nanocarriers for pulmonary/nasal delivery (small molecules and macromolecules/vaccines); smart responsive nanocarriers
Special Issues, Collections and Topics in MDPI journals
Interests: nanotechnology for the local and systemic delivery of phytochemicals; hybrid nano-carriers for mucosal; ocular and pulmonary delivery of therapeutics
Special Issue Information
Dear Colleagues,
Nutraceuticals (defined as components/nutrients isolated or purified from foods, which have medical or health benefits besides providing nutrition) have gained increased prominence in clinical applications. Nutraceuticals not only offer protection against numerous pathologies, including cardiovascular diseases, cancer, diabetes, arthritis, immunological, inflammatory, and neurodegenerative disorders, but are also used in the treatment of these conditions. The applications of nanotechnology in nutraceuticals are rapidly growing, with the main aim of enhancing their biological activities. The success of nutraceutical nanomedicines is attributed to the ability of nanocarrier technologies to improve the solubility, stability, and systemic bioavailability of the encapsulated active phytochemical ingredient(s). Moreover, novel nanocarrier systems can provide site-specific delivery of nutraceutical cargo, in addition to its controlled/sustained release from the nano-formulation, thus enhancing the overall therapeutic efficacy.
The main aim of this Special Issue on "Nutraceuticals in Nanomedicine Applications" is to serve as an open forum where researchers may share their current findings, evaluations, and expert opinions in this ever-growing area of nutraceutical nanomedicines. Thanks to the current nanomedical evolution, the scope of this scientific development area has expanded to include novel hybrid (organic and in-organic/metalloid) nanoplatforms and nanocomposites, with varying nutraceutical cargos, such as semi-synthetic molecules, compounds, and conjugates, in addition to the traditional isolated or purified components. The broad focus of this issue will include not only parenteral, topical, and oral routes of administration, but also mucosal and ocular delivery, as well as combination/coated medical devices, implants, and even wearables, which can be used for drug delivery and probing/sensing/diagnostic applications too.
Here, we invite both original research and review articles on all aspects of nutraceutical nanotechnology product development, to help increase their visibility and enhance the clinical prospects along with industrial applications of these advanced systems.
Prof. Dr. Tamer Elbayoumi
Prof. Dr. Imran Saleem
Dr. Satyanarayana Somavarapu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nutraceuticals
- supplements
- bioactive compounds/analogues
- semi-synthetic molecules, compounds, and conjugates
- disease prevention and treatment
- nanoformulations
- hybrid nanoplatforms/nanosystems
- combination/coated medical devices
- probing/sensing/diagnostic applications
- physico-chemical characterization
- bioavailability
- pharmacodynamics
- localized/systemic administration
- targeted delivery
- safety and efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
